Cargando…
Success for gene therapy: render unto Caesar that which is Caesar's
Reports that two young children developed leukemia after being treated for immunodeficiency with their own retrovirally modified bone-marrow cells delivered a severe blow to confidence in gene therapy as a treatment. Two reports, published since the trial was initiated, now take away some of the mys...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507871/ https://www.ncbi.nlm.nih.gov/pubmed/15287968 http://dx.doi.org/10.1186/gb-2004-5-8-237 |
_version_ | 1782121686385033216 |
---|---|
author | Qiao, Jian Diaz, Rosa Maria Vile, Richard G |
author_facet | Qiao, Jian Diaz, Rosa Maria Vile, Richard G |
author_sort | Qiao, Jian |
collection | PubMed |
description | Reports that two young children developed leukemia after being treated for immunodeficiency with their own retrovirally modified bone-marrow cells delivered a severe blow to confidence in gene therapy as a treatment. Two reports, published since the trial was initiated, now take away some of the mystery as to why these events happened and allay fears for the safety of gene therapy across all therapeutic applications. |
format | Text |
id | pubmed-507871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-5078712004-08-10 Success for gene therapy: render unto Caesar that which is Caesar's Qiao, Jian Diaz, Rosa Maria Vile, Richard G Genome Biol Minireview Reports that two young children developed leukemia after being treated for immunodeficiency with their own retrovirally modified bone-marrow cells delivered a severe blow to confidence in gene therapy as a treatment. Two reports, published since the trial was initiated, now take away some of the mystery as to why these events happened and allay fears for the safety of gene therapy across all therapeutic applications. BioMed Central 2004 2004-07-29 /pmc/articles/PMC507871/ /pubmed/15287968 http://dx.doi.org/10.1186/gb-2004-5-8-237 Text en Copyright © 2004 BioMed Central Ltd |
spellingShingle | Minireview Qiao, Jian Diaz, Rosa Maria Vile, Richard G Success for gene therapy: render unto Caesar that which is Caesar's |
title | Success for gene therapy: render unto Caesar that which is Caesar's |
title_full | Success for gene therapy: render unto Caesar that which is Caesar's |
title_fullStr | Success for gene therapy: render unto Caesar that which is Caesar's |
title_full_unstemmed | Success for gene therapy: render unto Caesar that which is Caesar's |
title_short | Success for gene therapy: render unto Caesar that which is Caesar's |
title_sort | success for gene therapy: render unto caesar that which is caesar's |
topic | Minireview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507871/ https://www.ncbi.nlm.nih.gov/pubmed/15287968 http://dx.doi.org/10.1186/gb-2004-5-8-237 |
work_keys_str_mv | AT qiaojian successforgenetherapyrenderuntocaesarthatwhichiscaesars AT diazrosamaria successforgenetherapyrenderuntocaesarthatwhichiscaesars AT vilerichardg successforgenetherapyrenderuntocaesarthatwhichiscaesars |